Register Now
Discover how Ebglyss (Lebrikizumab) works as a targeted IL-13 inhibitor in the treatment of Atopic Dermatitis (AD). Learn more about Ebglyss unique mechanism of action, binding with high affinity to IL-13 and slow dissociation rate1-12.
